Organization (Hospital)
Children's Hospitals and Clinics of Minnesota
ClinicalTrials.gov lists Children's Hospitals and Clinics of Minnesota as lead sponsor of 49 trials. It has 17 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Children's Minnesota, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Children's Hospitals and Clinics of Minnesota: 49 lead-sponsored trials and 0 legal-entity registrations.
Disease areas (91)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Pain | 9 |
| Emergencies | 7 |
| Obesity | 5 |
| Respiratory Distress Syndrome | 5 |
| Brain Neoplasms | 4 |
Showing 5 of 91 disease areas.
Trials by start year as sponsor or collaborator (18)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 4 |
| 2022 | 2 |
| 2021 | 2 |
| 2019 | 2 |
| 2018 | 1 |
| 2017 | 5 |
| 2016 | 4 |
| 2015 | 8 |
| 2014 | 8 |
Showing 10 of 18 years.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (17)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| IBUPROFEN | 2 |
| Codeine with acetaminophen | 1 |
| Tramadol suspension | 1 |
| TRAMADOL | 1 |
| Gabapentin | 1 |
Showing 5 of 17 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 33% hit target (n=6) | 20% on time (n=5) |
Journals published in (90)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Annals of emergency medicine | 13 |
| Pediatrics | 13 |
| Pediatric blood & cancer | 10 |
| Pain | 7 |
| Academic emergency medicine : official journal of the Society for Academic Emergency Medicine | 6 |
Showing 5 of 90 journals.
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| NAI | 7 |
Organization relationships (44)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| The Hospital for Sick Children | Co sponsors trial with | 4 |
| University of California System | Co sponsors trial with | 4 |
| Children's Healthcare of Atlanta | Co sponsors trial with | 3 |
| Timothy J Nelson, MD, PhD | Co sponsors trial with | 3 |
| Children's National Research Institute | Co sponsors trial with | 3 |
Showing 5 of 44 relationships.
Latest dated events (76)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2025-05-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-12-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-05-16 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-02-25 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-02-22 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 76 events.
CLIA clinical laboratory certificates (1)
| Lab | Certificate | Status |
|---|---|---|
| CHILDREN'S HOSPITALS & CLINICS OF MINNESOTA | Certificate of accreditation | Active |
Biomarker capability evidence (41)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CD34 | Trial collaborator | Named in trial inclusion criteria |
| CD44 | Trial sponsor | Named in trial inclusion criteria |
| CRP | Trial sponsor | Named in trial inclusion criteria |
| DICER1 | Testing lab / CRO (runs the assay) | Clinical-testing interpretation submitted (ClinVar) |
| DICER1 | Trial sponsor | Named in trial inclusion criteria |
Showing 5 of 41 evidence rows.
Biomarkers this organization publishes on (163)
Shown in this order: most publications first.
Showing 5 of 163 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, and workforce and board diversity, as filed.